DOAC in Patients with Child a or B Liver Cirrhosis
NCT05869591
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Liver Cirrhosis
Interventions
DRUG:
Apixaban 5 MG [Eliquis]
DRUG:
Edoxaban 60 MG [Lixiana]
Sponsor
Centre Hospitalier Universitaire Vaudois